Table 1.
Association of CD44 with molecular characteristics of breast tumors
| Association of CD44 expression with tumor characteristics | ||||||
|---|---|---|---|---|---|---|
| n (%) | CD44 n (%) | P | ||||
| CD44 | + | 84/141 (60%) | N/A | |||
| - | 57/141 (40%) | N/A | ||||
| ER | + | 121/140 (86%) | 73/121 (60%) | 0.025 Mann-Whitney, 0.019 t test |
||
| - | 19/140 (14%) | 16/19 (84%) | ||||
| PR | + | 96/140 (69%) | 56/96 (58%) | 0.021 Mann-Whitney, 0.025 t test |
||
| - | 44/140 (31%) | 33/44 (75%) | ||||
| Her2 | + | 13/133 (10%) | 75/120 (63%) | Not significant | ||
| - | 120/133 (90%) | 8/13 (62%) | ||||
| Basal | + | 15/135 (11%) | 13/15 (87%) | 0.018 Mann-Whitney, 0.021 t test |
||
| - | 120/135 (89%) | 72/120 (60%) | ||||
| Triple negative | + | 15/135 (11%) | 13/15 (87%) | 0.018 Mann-Whitney, 0.021 t test |
||
| - | 120/135 (89%) | 72/120 (60%) | ||||
| Expression of CD44 is expressed as a percentage of patients in individual clinical classifications (first column). | ||||||